Current evidence supports risk-adapted primary prophylaxis and individualized secondary prophylaxis for as long as clinically meaningful immunosuppression persists, complemented by infection-control measures in units caring for highly immunocompromised patients.
Jinnam Kim, Choseok Yoon, B. Kim et al.· The Korean Journal of Intern...· 0 citations
A systematic review and meta-analysis of ML-based BSI prediction models to quantify their discriminative performance and appraise the certainty of the evidence concluded that Rigorous external validation, calibration and decision-analytic reporting, and adherence to prediction-model reporting standards are needed befor...
Heejeong Kwon, Jaewoong Kim, Hyunok Yun et al.· International Journal of Med...· 0 citations
In CRE bacteremia, combination therapy did not confer a uniform survival advantage, but was associated with lower mortality in patients receiving colistin-based regimens and those with high comorbidity burden.
Yae Jee Baek, Se Yoon Park, Jung Ho Kim et al.· International Journal of Ant...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.